Background: Evidence synthesis reviews in health care rely on the efficient identification of research evidence, particularly evidence from randomised controlled trials (RCTs). There are no recently validated filters to identify RCTs in the Cumulative Index to Nursing and Allied Health Literature (CINAHL Plus). Objectives: To develop, test and validate a search filter to identify reports of RCTs from CINAHL Plus. Methods: Nine sets of relevant and irrelevant records were identified to develop and test search filters iteratively. Two sets were used to validate the sensitivity and precision of the filters. The performance of two previously published filters and the filter built into EBSCOhost was evaluated.
Introduction
Evidence synthesis in health care, from rapid reviews to the most extensive systematic review and health technology assessment projects, relies on the efficient identification of research evidence, in particular the evidence from randomised controlled trials (RCTs) (Agency for Healthcare (Cochrane Library, 2017 ). This database is available as part of the Cochrane Library (Cochrane, 2017) and contains more than 1 066 000 records (3 July 2017). Information specialists, librarians and systematic reviewers find this database as a time saving resource for the rapid acquisition of the trial literature in specific conditions. CENTRAL is built by collecting reports of RCTs from MEDLINE, EMBASE and a range of other resources (https://www.cochranelibrary. com/central/about-central). At present, however, records of RCTs indexed in the Cumulative Index to Nursing and Allied Health Literature (CINAHL Plus) are not available via CENTRAL.
CINAHL Plus is a long established and valuable resource for identifying research publications in nursing and allied health. It contains more than 6 million records (25 January 2019) and indexes nearly 5500 journals (EBSCO Industries, 2019). CINAHL Plus is published by EBSCO Industries. Typically, searchers seeking to identify reports of RCTs in databases will look to use search filters. Search filters are standardised and (ideally) validated search strategies designed to find specific study designs such as RCTs (InterTASC, 2019) and are seen as time saving means to focus subject searches on specific research designs. A search of the ISSG Search Filter Resource indicates that there are only two filters to find reports of RCTs in CINAHL. One filter is a non-validated filter published by the Scottish Intercollegiate Guidelines Network (SIGN), and the second (Wong et al.) was developed in 2006 (Scottish Intercollegiate Guidelines Network, 2017; Wong, Wilczynski & Haynes, 2006) and may no longer be current. Wong et al.'s strategy was designed to capture treatment studies which might make it more sensitive and less precise than a filter designed to capture reports of RCTs (Wong et al., 2006) . There is no recent validated filter designed specifically to identify reports of RCTs in CINAHL. A failure to identify reports of RCTs in CINAHL may mean that studies that might be relevant to systematic review questions might be overlooked and nurses seeking reports of RCTs to inform their practice may miss studies.
The Cochrane Editorial Unit (CEU) is exploring ways to improve the identification of RCTs either through adding records to CENTRAL or by providing search filters which can be used by researchers searching for studies to include in reviews. In 2016, the CEU commissioned York Health Economics Consortium (YHEC) to develop and validate a sensitive search filter to identify reports of RCTs, quasi-RCTs and controlled clinical trials from CINAHL Plus. This filter is intended to provide a tool for researchers seeking to identify records in CINAHL Plus using those study designs, to inform systematic reviews and other evidence syntheses. This paper reports the development, testing and validation of the search filter.
Methods
Our filter development process made use of text analysis tools to analyse known relevant records (a series of reference sets or gold standards) and to identify search terms which would discriminate relevant records from non-relevant records. The performance of candidate filters in finding relevant records among batches of relevant and non-relevant records was tested iteratively until a filter which performed consistently highly was identified. The resulting filter was then validated against a further set of records which had not been used in the development of the filter. These methods are described in more detail in the following sections.
Defining a relevant record
Relevant records were determined to be those that would be eligible for inclusion in the CENTRAL database using the following definitions:
. . .randomised controlled trials (. . . RCT) . . . randomised trials, or controlled trials that may have been randomised or used a quasi-randomisation technique, such as allocating participants to treatment or placebo based on date of birth (. . .).
A randomised controlled trial is a particular way to run an experiment. . . looking to test the effects of an intervention (the intervention might be a drug, a device, a form of therapy etc.) . . . Each person within the study is randomly allocated to the intervention (a new drug or a new device or a new therapy) or a comparator (a sugar pill/placebo, or quite often just treatment as usual or another treatment). (The Cochrane Collaboration, 2017a)
Development of the gold standards
We obtained nine sets of 1000 CINAHL Plus records that had been categorised by a single Cochrane selector (SW) as reporting relevant (reporting RCTs, controlled clinical trials or quasiRCTs) or non-relevant studies, to use to develop lists of candidate search terms, to test candidate strategies and to validate filters.
No filters or condition/intervention search terms were applied to finding the sets of records. Records for the first three batches were selected nonrandomly, in lead author last name alphabetical ordering. Records for batches 4-9 were selected randomly. This was achieved by extracting random samples from the full sets of downloaded records using the Java java.util.Random class (which uses a 48-bit seed, modified using a linear congruential formula).
One set of 2000 CINAHL Plus records that had been screened by one trial selector (SW) was identified and was used to validate the search filters (validation set 1).
A further set of 2000 CINAHL Plus records that had been screened by the Cochrane Crowd (http:// crowd.cochrane.org) was randomly selected from the full set of downloaded records using the Java java.util.Random class (which uses a 48-bit seed, modified using a linear congruential formula) (The Cochrane Collaboration, 2017b). These records were used to validate the search filters (validation set 2). For records to be selected as a trial using the Crowd, the following algorithm was used: each record required four consecutive agreement classifications for the record to be deemed to be an RCT or not an RCT. Any breaks in the consecutive chain meant the record would be resolved by resolver level screeners (individuals, such as SW, in Cochrane Crowd with extensive experience and a proven track record of performing the task very well). For this Crowd task, 5% of records need resolving.
All of the batches of records included a large proportion with no abstract: this reflects the fact that a large proportion of records within CINAHL Plus have no abstract. Despite having accession numbers from sets of known CINAHL Plus records, when we reloaded accession numbers into CINAHL Plus, often fewer records were returned than expected. We do not understand yet why this happens but we suspect that there are multiple records for some publications, which CINAHL Plus identifies and tidies up periodically.
Identifying search terms to test
We used an objective approach to identify search terms using the terms available within records to determine which terms to test out in candidate strategies, rather than using previous filters or the research team's views on what might be useful search terms. We used the records in test set 1 to identify search terms. Test set 1 comprised 25 relevant records and 973 non-RCTs. The term identification process involved two steps. The relevant and non-relevant records were loaded into SimStat software (Provalis Research, 2017a) . With the aid of the Wordstat (Provalis Research, 2017b) subprogram, the frequency of phrases within the CINAHL Plus subject headings field only was analysed first (Appendix B). Those subject headings that described research methods and were predictive of being RCTs, according to the chisquare test, were identified. The prediction table was generated by using the Extraction, Phrase Analysis command and selecting the hierarchy option. CINAHL subject headings were then selected based on the heading being about methods and having a significance of 0.05 or less.
The performance of the subject headings was tested to assess the extent to which the various terms provided unique results. The records that were missed by using the subject heading only terms were then reviewed by one researcher (JMG). From these few missed records, additional search terms from the titles and abstracts were identified manually by the researcher (rather than using textual analysis software) and added to the candidate strategy. We also tried to select title and abstract words according to Hausner (Hausner, Waffenschmidt, Kaiser & Simon, 2012) (terms present in at least 20% of the references), but none of the words were present in at least 20% of the records. At this stage a test was conducted to evaluate the volume of animal studies that might be included and to help to decide whether to devote time to developing additional terms to exclude animal studies. The exploratory test had used a very pragmatic and simple approach involving one subject heading (MH): MH (rats).
Iterative testing and development of the filter
The sensitivity (number of relevant RCTs identified by the filter divided by the number of relevant RCTs in a specific test set) and precision (number of relevant RCTs identified by the filter divided by the number of records retrieved by the filter) of filter 1 in test set 1 were tested in EBSCO CINAHL Plus. To test the filter, we identified the test set 1 records (relevant and irrelevant records) in CINAHL Plus using their accession numbers and combined the test set records with the filter search terms (the detailed results are reported in Table A5 in the Appendix A).
We then iteratively developed filters based on their performance in the test sets and tested each new filter until we reached a filter that performed with very high sensitivity and high precision. The various search terms tested and the test sets in which they were tested are described in Table A1 of the Appendix A. Following iterative testing, development moved on from the subject terms to evaluate the volume of animal studies that might be included and to explore whether to devote time to developing additional terms to exclude animal studies (filters 3, 4, 5 and 6 tested in test sets 6 and 7).
Filter validation
Filters 6 and 9 were validated on validation set 1 (52 relevant records and 1922 irrelevant records) and validation set 2 (65 definitely or possibly relevant records and 1932 irrelevant records).
We also tested the performance of three other filters on validation set 2 to compare their performance to the filters we had developed: • The high sensitivity therapy filter that is built into EBSCOhost implementation of CINAHL Plus. This filter is accessed from the Advanced Search option and is one of the Clinical Query options in the 'Limit your results' section. Table 1 shows the number and proportion of records in the test and validation sets with abstracts, the number of records with no author (anonymous) and the method by which the relevance of records was assessed.
Results

Test sets
Search filter performance
The performance of the filters in the test sets is provided in the Table A5 . Table 2 shows the validation results. Filter 9 was the most sensitive filter in validation set 1 with the added benefit of 0.30 precision. When validated in validation set 2, which were records assessed by the Cochrane Crowd, the filter showed a slightly lower sensitivity (0.88), but an increased precision (0.36). Filter 9 is labelled the Cochrane CINAHL Plus filter (Table 3) .
We also tested the performance of two published filters against the validation 2 set of records and also the high sensitivity CINAHL Plus filter that is built into EBSCOHost ( Table 2 ). The SIGN non-validated filter achieved marginally better (0.91) sensitivity to the Cochrane CINAHL Plus filter, but had substantially poorer precision (0.12) (Scottish Intercollegiate Guidelines Network, 2017). The Wong et al. filter had a similar sensitivity (0.88), but a much poorer precision (0.07) than the Cochrane CINAHL Plus filter (Wong et al., 2006). The high sensitivity therapy filter that is built into EBSCOHost CINAHL Plus achieved 0.85 sensitivity and 0.11 precision, making it the least sensitive and the second least precise strategy in this validation.
Discussion
We have developed a sensitive and precise search filter to retrieve reports of RCTs, quasi-RCTs and controlled clinical trials in CINAHL Plus. The filter performs similarly in terms of sensitivity to two published filters, but with substantial improvements in precision (Scottish Intercollegiate Guidelines Network, 2017; Wong et al., 2006). The filter benefits from the availability of a number of relevant CINAHL Plus subject headings which seem to be applied with a high level of consistency. This helps with achieving both sensitivity and precision. The filter also benefits from careful exclusions to achieve precision. The filter has been developed iteratively on many test sets and has been validated on validation set of records which were separate from the testing records. We have also been able to validate the two published filters, one of which had previously not been formally validated (Scottish Intercollegiate Guidelines Network, 2017; Wong et al., 2006).
We explored the reasons why some records were not retrieved by the Cochrane CINAHL Plus filter from the validation sets. This exploration showed the challenges inherent in trying to improve sensitivity in CINAHL Plus. In validation set 1, we found challenges stemming from inadequate study design description: one record (accession number 104040914) reported on different 'groups', but other than the word 'group', there were no other words that might signal that this was a controlled trial. Another record (accession number 104039164) was more clearly a comparative study with signal words such as 'assigned to' and 'vs', but to expand the strategy to include these terms would have significant impacts on precision. A further record (accession number 104040070) had the phrase 'prospective multicentre study' in the title, was indexed with 'prospective studies', but lacked an abstract to provide more detail that might indicate that it was comparative. The indexing, however, also included the heading 'nonexperimental study' which might suggest this was not a trial, as does the absence of a comparator in the title. The record is likely to have been selected based on the signal words and screeners erred on the side of inclusion in the absence of an abstract. The fourth missed record (Accession number 103875440) has the signal words 'assigned to' and 'groups', but otherwise no indication that it is a prospective controlled trial. The final missed record (Accession number: 107781619) had no abstract, but has 'compared with sham group' in the title. The brevity of the document, however, suggests this may be a news item. Three of the five missed records from the validation set 1 would have been retrieved if search terms such as 'group', 'groups' or 'assigned' were to be added to the filter. In validation set 2, whose records had been assessed by the Cochrane Crowd, four of the missed records had few words signalling the study design and four records had no abstract. However, some of the missed records could be retrieved if single terms such as 'group', 'groups' 'multicentre' or 'before NEAR after' were added to the filter.
The additional terms identified from the missed records in the two validation sets are not highly discriminating, and, if included in a search filter, they are likely to result in reduced precision. Searchers can add such terms into the filter to increase sensitivity but should do so with the awareness that precision will suffer, often for small gains in sensitivity. However, if the results are being imported into machine learning applications such as the Cochrane Classifier, then more sensitive search approaches, with the addition of these terms which are likely to reduce precision, may be acceptable (Wallace et al., 2017). In this case, the expectation would be that the Classifier would remove many of the irrelevant records retrieved by more sensitive searches.
The missed records illustrate two issues which hamper record identification and efficient record categorisation from CINAHL Plus. One is the high proportion of records without abstracts. In test set 1, for example, 60% (595/998) of the records had no abstract, and in validation set 1, 66% of the records (1297/1974) had no abstract. This feature of CINAHL Plus means that many of its records cannot be genuinely assessed as a trial without access to the full paper and it probably leads Cochrane Crowd record assessors and other selectors to err on the side of categorising the records as reports of trials (i.e. an include) rather than excluding them based on the limited information provided.
The second issue is the absence of explicit study design and methods descriptions within abstracts, which is clearly still a problem several years after the introduction of the CONSORT reporting guidance (Hays et . Human readers looking at records that mention 'groups' and assignment to 'groups' can make the assumption that the record may be the report of a comparative trial, but there is often very little other information in the record to substantiate this decision. The knock-on effects of inadequate methods descriptions are that researchers waste time categorising records inaccurately and waste money buying and verifying publications which PT (randomized controlled trial) S13 AB (control W5 group) S14 MH (crossover design) OR MH (comparative studies) S15 AB (cluster W3 RCT) S16
MH animals+ S17 MH (animal studies) S18 TI (animal model*) S19 S16 OR S17 OR S18 S20 MH (human) S21 S19 NOT S20 S22 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 S23 S22 NOT S21 Key MH CINAHL Plus subject heading + explode subject heading AB Word in abstract TI Word in title MODEL* Truncated word W3
Within three words may turn out not to be reports of trials. Records of brief publications, which are likely to be editorials or news items, may also be poorly labelled and again might result in unnecessary waste of time and expense. As with many indexed databases, there is inevitably scope for records to be misindexed. We did find examples of this, for example record 103858571 is a registry study but is indexed as a RCT. However, such examples were few in the samples we assessed.
Retrieving records efficiently is also hampered by the presence of title and abstract words which are used 'in passing' rather than forming the core focus of the record. Many irrelevant records are retrieved because the final line of their abstracts contains a recommendation for the future conduct of RCTs.
Limitations of this study
Test sets 1 to 3 were not all selected by random sampling. This is not ideal but was a pragmatic solution to be able to develop some test sets with the resources available to the project. This approach might run the risk that some records would only be from a few journals. However, inspection of the records in the test sets that were not randomly generated does not show that whole issues of journals were included. Alternatively, selecting in author order might run the risk of result sets being dominated by high publishing authors. Again, inspection of those test sets shows that most authors appeared only once, with very few authors appearing more than four times. Since authors name did not feature in the filter terms neither the absence nor presence of authors nor the authors' actual names, would impact the filter performance. To compensate, the other test sets and validation sets were selected by random sampling.
Records used to develop and validate this filter were selected based on an assessment of relevance using information in the titles, abstract and indexing of records. The full text of the records was not assessed. This means that some studies that are reports of RCTs might not be identified from the information in the database record and, conversely, that the inclusion of records without inadequate information may be producing false positives. To minimise these impacts, we chose a reviewer to categorise the records (SW) who has extensive experience in citation screening for RCTs. SW has worked as the lead resolver on Cochrane Crowd (resolving disagreements between novice Crowd contributors categorising database records as likely to be RCTs), and her individual performance in that task has been evaluated and shown to be very reliable. Best practice, in all record screening, is to be inclusive when there is doubt about eligibility. The validation sets were collected using multiple selectors and the filter performance in these sets was maintained, suggesting that the selection in the test sets was not so different from the validation sets. However, users should be aware that selection of records was not made based on the full text of records.
The test set records represent records mostly from recent years to ensure filter currency going forward. This does mean that the performance of the filter may be skewed to more recent studies which may differ from older studies in terms of the clarity or detail of methods reporting. We suspect that performance might be less sensitive in older studies since we know that the reporting of controlled trials has improved somewhat in the years since the publication of the CONSORT statement (Hays et al., 2016; Schulz et al., 2010; Stevanovic et al., 2015) . However, when we compare the sensitivity of our filter with the filter suggested by Wong et al., which is over a decade old, we encountered very similar performance, which might suggest that retrieval is more stable over time than we had anticipated (Wong et al.,  2006) .
The use of a single selector (ANS or SW) to screen the eligible records in the test sets and validation set 1 may have led to an unknown level of selection errors, since the selection was not independently checked. This may mean that relevant studies were missed or that ineligible studies were wrongly classed as eligible in those three test sets. However, we note that the experienced selectors were asked to be overinclusive in their selection decisions, hopefully minimising missed studies. When compared to a set of 2000 records screened by the Cochrane Crowd, we did not see any great reduction in sensitivity, which suggests the selector was performing similarly to the Cochrane Crowd. Given the high proportion of records without abstracts, any screeners, including Cochrane Crowd members, will tend to be overinclusive.
Conclusions
A sensitive and precise filter was developed using records selected based on title and abstract information to identify reports of RCTs, controlled clinical trials and quasi-RCTs from the CINAHL Plus database. The filter can be made more sensitive, but less precise, with the addition of other terms. The precision of the filter is such that it is likely to offer significant advantages over using subject searches alone, and over other published filters and the filter included within EBSCOhost. It is likely to cut the number of results that need to be scanned by researchers for a review substantially compared to the number retrieved by a subject search alone. In terms of other published filters, the Cochrane CINAHL Plus filter will reduce the number of records needed to screen by 75%. Appendix A
This appendix contains additional detail on the methods used in the paper. Table A1 provides the sequence of filters tested during the development of the Cochrane CINAHL filter. The development process relating to the sequence of filters is described here:
We began with test set 1 to develop the filter iteratively. After each test we identified search terms that were in the relevant records that were not retrieved and tested out the impact of their addition to the strategies.
When we reached filter 3 we tested it on test set 3 and then on test set 4. Following testing, the filter was not revised since no records were missed that could contribute additional search terms to test out. Filter 3 was validated on test set 5 which comprised 35 relevant records and 959 non-RCTs.
Then we moved on to try to remove animal studies. Filter 3 was revised to become filter 4, with the addition of further animal study exclusion terms, as well as additional relevant search terms. Filter 4 was tested on test set 6. Filter 4 was amended as a result, and renamed as filter 5.
Filter 5 was tested on test set 6. It was also tested on test set. As a result the filter was amended and became filter 6.
Exploring how to improve precision further, at this point we had conducted a series of iterations and reached the point at which we did not feel we could improve the sensitivity further. We changed focus to explore approaches to improve precision further. We used filter 6 to search all of test sets 1 to 7 and then explored the title, abstract and subject indexing of the non-RCT records retrieved to look for ways improve the search filter precision.
As a result of this assessment we amended filter 6 and provided a set of additional optional exclusions which searchers might wish to add if the volume of records retrieved was unmanageable. This resulted in filters 7 and 8. The exclusions were only applied to records with abstracts, since the exclusions would be too stringent in records with only title and indexing.
The performance of filters 6, 7, and 8 on test sets 1 to 7 was tested (see Table A5 ). We decided to proceed only with filter 6 at this stage since the precision optimisation exercise captured in filters 7 and 8 had not impacted the sensitivity and precision markedly. We amended filter 6 to be more sensitive by adding in 'random*' as a textword and labelled this filter 9. Filters 6 and 9 was tested on test set 8 and test set 9.
At this point we felt that we had achieved the best we could achieve within the resources available to the project and given the high proportion of records with no abstract.
Tables A2-A4 provide the published filters that were tested against the Cochrane CINAHL filter. Table A5 shows the detailed results of the filter testing. 21 . S18 OR S19 OR S20 22. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 23. S22 NOT S21 CINAHL for EBSCO (created by Mark Clowes) # Query S12 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 S11 TX allocat* random* S10 (MH "Quantitative Studies") S9 (MH "Placebos") S8 TX placebo* S7 TX random* allocat* S6 (MH "Random Assignment") S5 TX randomi* control* trial* S4 TX ((singl* n1 blind*) or (singl* n1 mask*)) or TX ((doubl* n1 blind*) or (doubl* n1 mask*)) (continued) or TX ((tripl* n1 blind*) or (tripl* n1 mask*)) or TX ((trebl* n1 blind*) or (trebl* n1 mask*)) S3 TX clinic* n1 trial* S2 PT Clinical trial S1 (MH "Clinical Trials+") MH (prognosis+) MH ("study design+") TX random* S1 OR S2 OR S3 Table A4 EBSCOHost CINAHL Plus Therapy High Sensitivity filter ((MH "prognosis+" not MM "prognosis+") or (MH "study design+" not MM "study design+") or (TI random* or AB random* or MW random*)) Source: https://help.ebsco.com/interfaces/CINAHL_MEDLINE_Databases/CINAHL/search_strategies_used_by_CINAHL_Clinica l_Queries. 
